{"id":"W2103524303","doi":"10.1016/s0140-6736(15)61134-5","title":"Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial","year":2015,"lang":"en","type":"article","venue":"The Lancet","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":850,"is_retracted":false,"has_abstract":false,"ca_institutions":"Memorial University of Newfoundland","funders":"Medical Research Council; National Institute for Health and Care Research","keywords":"Secukinumab; Medicine; Psoriatic arthritis; Placebo; Internal medicine; Clinical endpoint; Rheumatology; Arthritis; Placebo-controlled study; Gastroenterology; Clinical trial; Immunology; Double blind; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002368639,0.00206027,0.00346847,0.0004508972,0.0005127703,0.001139124,0.000772001,0.002555331,0.006526041],"category_scores_gemma":[0.001838117,0.0007104845,0.002997119,0.0004795205,0.001212953,0.001331799,0.000415281,0.003372445,0.001128625],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006890817,"about_ca_system_score_gemma":0.0009266249,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001088666,"about_ca_topic_score_gemma":0.002638417,"domain_scores_codex":[0.9993242,0.000335542,0.00004411106,0.0001105301,0.00006265244,0.0001229582],"domain_scores_gemma":[0.9992501,0.0002292545,0.000150183,0.00005647706,0.00005705001,0.000256913],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9789413,0.002195291,0.0004638556,0.0009547878,0.001104714,0.00005040801,0.00006057938,0.0001885066,0.001842124,0.0001036627,0.001176477,0.01291835],"study_design_scores_gemma":[0.9744312,0.02334918,0.0009612365,0.00003621346,0.0003747164,0.00003515993,0.0000170254,0.0001084951,0.0001429661,0.00008557909,0.0004480019,0.00001027189],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9598922,0.0255623,0.001018995,0.001926485,0.001790379,0.003949013,0.002103008,0.0002307522,0.003526902],"genre_scores_gemma":[0.9711174,0.0113755,0.001903158,0.003034249,0.001048477,0.004181494,0.001963153,0.00004184781,0.005334743],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006526041,"threshold_uncertainty_score":0.02183181,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03332117750479653,"score_gpt":0.3242151394148892,"score_spread":0.2908939619100926,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}